Search Results - Alexa B. Kimball, MD, MPH

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infant by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded... by Simon J. Gunter, MPhil, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Career satisfaction of leaders in academic dermatology: Results from a national survey, by Mona Sadeghpour, MD, Sarah M. Sung, MD, Heidi Jacobe, MD, MSCS, Alexa B. Kimball, MD, MPH

Connect to this object online.

Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study by Ruby S. Gibson, MD, Corey L. Snyder, BSA, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study by Diana S. Kim, BA, Nicole Giannotti, BS, Prerna Salian, MPH, Alexa B. Kimball, MD, MPH, Martina L. Porter, MD

Connect to this object online.

Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis by Charlotte Greif, MD, Ruby S. Gibson, MD, Alexa B. Kimball, MD, MPH, Zachary E. Holcomb, MD, Martina L. Porter, MD

Connect to this object online.

Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review by Corey L. Snyder, MD, Ruby S. Gibson, MD, Stella X. Chen, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients by Kevin T. Savage, BA, Monica Rosales Santillan, MD, Kelsey S. Flood, MD, Alexandra Charrow, MD, MBE, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Challenges for dermatologists during the COVID-19 pandemic: A qualitative study by Matthew F. Helm, MD, Alexa B. Kimball, MD, MPH, Melissa Butt, MPH, Heather Stuckey, MEd, DEd, Heather Costigan, BS, Kanade Shinkai, MD, PhD, Arielle R. Nagler, MD

Connect to this object online.

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities by Peyton C. Morss-Walton, BA, Charlotte Greif, BA, Zachary E. Holcomb, MD, Prerna Salian, MPH, Tuyen Yankama, MPH, Diana Kim, BA, Martina L., Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa by Kevin T. Savage, BA, Elena Gonzalez Brant, MD, Monica Rosales Santillan, MD, Peyton C. Morss, BA, Prerna Salian, MPH, Kelsey S. Flood, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Connect to this object online.